Fig. 2
From: COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma
COL10A1 is elevated in pancreatic adenocarcinoma and associated with a poor prognosis in PAAD patients. (A) The mRNA expression of COL10A1 in pancreatic adenocarcinoma tissues (n = 179) and normal pancreatic tissues (n = 171) (*, P < 0.05). (B) COL10A1 expression in pancreatic cell lines (Panc-1, BxPC-3, ASPC-1 cells) and the human normal pancreatic duct epithelial cell line HPDE6-C7 was examined by qRT‒PCR (*, P<0.05; **, P<0.01). (C) Overall survival (OS) analysis of PAAD patients grouped based on COL10A1 expression level using the LinkedOmics database (P = 1.923 × 10− 3)